Enjoy complimentary customisation on priority with our Enterprise License!
The zika virus therapeutics market size is forecast to increase by USD 4.17 billion at a CAGR of 4.5% between 2023 and 2028. The Zika virus infection continues to pose a significant health concern, particularly in relation to severe birth defects, such as microcephaly, which can result from mother-to-fetus transmission or sexual contact with an infected partner. The drug market for potential treatments against Zika virus is gaining momentum due to the increasing number of cases and the need for effective interventions. Laboratory studies have shown that small molecule inhibitors, such as Emricasan, exhibit antiviral activity against Zika virus by targeting host proteins, specifically caspase-8, which plays a role in viral replication. Moreover, efforts by both government and private organizations to develop vaccines against Zika virus are intensifying. The asymptomatic nature of the infection in many cases complicates diagnosis and treatment, making the availability of serology kits for qualitative diagnosis of Zika virus infection crucial.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.